DAAN Biotherapeutics logo — Innovative treatments for cancer: empowering patients with a...

DAAN Biotherapeutics

Innovative treatments for cancer: empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors.

Founded 2020 Seed Total: $5.00B Biotechnology, Health Care +1

General Information

Company Name DAAN Biotherapeutics
Founded Year 2020
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

Get notified when DAAN Biotherapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DAAN Biotherapeutics

DAAN Biotherapeutics is a biotechnology startup founded in 2020, dedicated to developing innovative treatments for cancer. Their focus lies in empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors. The company has recently received a KRW5.00B Seed Round investment on 28 March 2022 from a group of prominent investors including Company K Partners, Aju IB Investment, NS Investment, Timefolio Asset Management, Paratus Investment Inc., DONGYU Investment. With a mission to provide novel solutions for cancer treatment, DAAN Biotherapeutics is making significant strides in the biotechnology and health care industries. Their research and development efforts span a wide spectrum, encompassing a range of promising avenues in cancer therapy, from cell-based approaches to molecular targeting. As they continue to drive groundbreaking advancements in the field, DAAN Biotherapeutics holds immense potential to revolutionize cancer treatment and make a lasting impact on global health.

Taxonomy: cancer treatment, cell therapies, antibodies, small molecule inhibitors, novel treatments

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 6
Investor Investor Investor Investor
•••• ••••
28 Mar 2022

DAAN Biotherapeutics Alternatives & Competitors

DAAN Biotherapeutics vs

Founded in November, 2014, Genecast (Beijing) Biotechnology Co. is located in HealthWork (Beijing) I...

Series E
21 employees
Biotechnology, Health Care
DAAN Biotherapeutics vs

Every minute, every hour, every day we’re working towards a cancer free future.

110 employees
Health Care
DAAN Biotherapeutics vs

Colorado’s only National Cancer Institute-Designated Comprehensive Cancer Center.

109 employees

FAQ About DAAN Biotherapeutics

Innovative treatments for cancer: empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors.
DAAN Biotherapeutics was founded in 2020.
DAAN Biotherapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
DAAN Biotherapeutics has completed 1 funding round, raising a total of $5.00B. The latest funding stage is Seed.
Top alternatives and competitors to DAAN Biotherapeutics include GeneCast Biotechnology Co., Ltd., Cancer Council Australia, University of Colorado Anschutz Cancer Center, CBMC Cancer Center, Huntsman Cancer Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DAAN Biotherapeutics and GeneCast Biotechnology Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DAAN Biotherapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy